223 related articles for article (PubMed ID: 1690913)
1. Utility of ascitic fluid analysis in patients with malignancy-related ascites.
Salerno F; Restelli B; Incerti P; Annoni G; Capozza L; Badalamenti S; Lampertico P; Mojana E; Moser P; Tommasini M
Scand J Gastroenterol; 1990 Mar; 25(3):251-6. PubMed ID: 1690913
[TBL] [Abstract][Full Text] [Related]
2. [Immunological parameters in the differential diagnosis of ascites secondary to peritoneal carcinomatosis, hepatic cirrhosis, and congestive heart failure].
Roldan-Molina F; de Oliveira e Silva A; dos Santos TE; Genzini T; de Miranda MP; de Oliveira RM; Santo GC; D'Albuquerque LA
Arq Gastroenterol; 1992; 29(2):56-61. PubMed ID: 1284885
[TBL] [Abstract][Full Text] [Related]
3. [Fibronectin in the ascitic fluid: its diagnostic significance].
Mal F; Nizard G; Labadie H; Trinchet JC; Garnier M; Beaugrand M
Gastroenterol Clin Biol; 1987 Oct; 11(10):639-42. PubMed ID: 2826281
[TBL] [Abstract][Full Text] [Related]
4. [Biochemical markers of the tumor origin of ascites].
Romette J; di Costanzo-Dufetel J
Pathol Biol (Paris); 1989 Jun; 37(6):720-4. PubMed ID: 2780109
[TBL] [Abstract][Full Text] [Related]
5. The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology.
Sari R; Yildirim B; Sevinc A; Bahceci F; Hilmioglu F
Hepatogastroenterology; 2001; 48(42):1616-21. PubMed ID: 11813585
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of ascitic fluid in patients with liver cirrhosis and hepatocellular carcinoma].
Takezaki E; Murakami S; Nishibayashi H; Kagawa K; Ohmori H
Gan No Rinsho; 1990 Nov; 36(14):2415-9. PubMed ID: 1979086
[TBL] [Abstract][Full Text] [Related]
7. Ascites in the state of Qatar: aetiology and diagnostic value of ascitic fluid analysis.
Khan FY
Singapore Med J; 2007 May; 48(5):434-9. PubMed ID: 17453102
[TBL] [Abstract][Full Text] [Related]
8. Fibronectin, cholesterol and triglycerides ascitic fluid concentration in the prediction of malignancy.
Colloredo Mels G; Bellati G; Auriemma L; Perani C; Leandro G; Vacca N; Pinna N; Alfieri G; Ideo G
Ital J Gastroenterol; 1991 May; 23(4):179-86. PubMed ID: 1661195
[TBL] [Abstract][Full Text] [Related]
9. [Ascitic fluid: benignancy and malignancy parameters].
Fluixá Carrascosa F; Rull Segura S; Devesa Jorda F; Martín Estruch A; Tur Cotaina MD; Borghol Hariri A; Pérez Serra J
Rev Esp Enferm Dig; 1996 Jan; 88(1):35-8. PubMed ID: 8615999
[No Abstract] [Full Text] [Related]
10. [Concentration of lipids in ascitic fluid and the concentration gradient of albumin in blood and ascites: diagnostic significance].
Barbare JC; Diab G; Delavenne J; Philippe JM; Vorhauer W; Latrive JP; Capron JP
Ann Gastroenterol Hepatol (Paris); 1989 Nov; 25(6):251-6. PubMed ID: 2619252
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of ascitic fluid lactic dehydrogenase, protein, and WBC levels.
Boyer TD; Kahn AM; Reynolds TB
Arch Intern Med; 1978 Jul; 138(7):1103-5. PubMed ID: 666469
[TBL] [Abstract][Full Text] [Related]
12. Alpha feto-protein and albumin in ascitic fluid in hepatocellular carcinoma patients.
Sadek A; Abdel Hady A; el Ayyat A; Hassan M; Mostafa I; Nouh A
J Egypt Soc Parasitol; 1997 Aug; 27(2):455-64. PubMed ID: 9257984
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic value of laboratory examination of ascites fluid (author's transl)].
Wördehoff D
Leber Magen Darm; 1981 Jan; 11(1):25-30. PubMed ID: 6163937
[TBL] [Abstract][Full Text] [Related]
14. Study of effusion cytology in patients with simultaneous malignancy and ascites.
Jha R; Shrestha HG; Sayami G; Pradhan SB
Kathmandu Univ Med J (KUMJ); 2006; 4(4):483-7. PubMed ID: 18603959
[TBL] [Abstract][Full Text] [Related]
15. Value of ascitic fibronectin and cholesterol concentration in the differentiation between malignancy-related and non-malignant ascites.
Archimandritis A; Kapsalas D; Douvara M; Tjivras M; Tsirantonaki M; Fertakis A
Ann Med Interne (Paris); 1996; 147(3):145-50. PubMed ID: 8796090
[TBL] [Abstract][Full Text] [Related]
16. [Genesis of fibronectin in ascites--detection of cellular and plasma fibronectin in portal and malignant ascites].
Rieder H; Ramadori G; Meyer zum Büschenfelde KH
Z Gastroenterol; 1991 Jan; 29(1):16-21. PubMed ID: 2058224
[TBL] [Abstract][Full Text] [Related]
17. [Differentiation of malignant and non-malignant origin of ascites by determination of levels of cholesterol and lactate dehydrogenase in ascitic fluid is not absolute].
Gasko R; Klímová N
Vnitr Lek; 2000 Jan; 46(1):5-11. PubMed ID: 10953656
[TBL] [Abstract][Full Text] [Related]
18. [Carcinoembryonic antigen (CEA) in ascites].
Coenen C; Schmidt G; Wegener M; Wedmann B; Bauer KH; Ricken D
Fortschr Med; 1991 Apr; 109(13):280-2. PubMed ID: 2066045
[TBL] [Abstract][Full Text] [Related]
19. Ascitic fluid concentrations of fibronectin and cholesterol: comparison of differential diagnostic value with the conventional protein determination.
Gerbes AL; Xie YN; Mezger J; Jüngst D
Liver; 1990 Jun; 10(3):152-7. PubMed ID: 2385156
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal fluid lactate dehydrogenase in ovarian cancer.
Schneider D; Halperin R; Langer R; Bukovsky I; Herman A
Gynecol Oncol; 1997 Sep; 66(3):399-404. PubMed ID: 9299252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
